Pfizer

The cover story in this weekend's Barron's offers a look at the worst start to the new year for stock markets ever. Barron's thinks the selling may be almost over and picks stocks worth buying now. Other feature stories include the Barron's Mutual Fund Quarterly. With the Dow Jones Industrial...

Following months of takeover talks, Pfizer Inc. (NYSE: PFE) announced on Monday it has acquired Allergan PLC (NYSE: AGN) for around $155 billion. The combination of Pfizer and Allergan marks the largest consolidation in the healthcare space. Presidential candidates publicly opposed the...

Shares of Allergan PLC (NYSE: AGN) and Pfizer Inc. (NYSE: PFE) were both trading lower by nearly 2 percent early Thursday morning. CNBC, citing sources, said the two companies are in the "final stages" of discussions to merge. CNBC added that it is expected to be an all-stock...

The cover story in this weekend's Barron's takes a look at who benefits from new cloud chip technologies. This issue also includes picks from the Barron's Emerging Markets Roundtable, as well as a closer look at inflation indexes. The prospects for Kinder Morgan, Pfizer, Avis...

The earnings crunch continues this week as the month of July winds down. Among the week's highlights will be results from social media giants Facebook Inc (NASDAQ: FB) and Twitter Inc (NYSE: TWTR). Wall Street analysts are expecting strong top line growth from both and gains in earnings as well....

Credit Suisse reviewed its stances on major U.S. pharma names in a note this week, though the analysts came to the same conclusion that Bristol-Myers Squibb Co (NYSE: BMY) and Pfizer Inc (NYSE: PFE) were the best in class. The analysts also noted that they have an Outperform rating on AbbVie Inc...

The first-quarter earnings season rolls on this week, and perhaps the most anticipated report of the week, if not the quarter, will come from Apple Inc. (NASDAQ: AAPL). Investors and Wall Street are looking for spectacular results. Analysts' forecasts also call for earnings growth from Time Warner...

Eli Lilly and Co (NYSE: LLY) came out with mixed first-quarter earnings Thursday. EPS for the company, excluding items, came at $0.50 versus $0.67 reported for the same quarter last year. Derica Rice, Eli Lilly CFO, was on CNBC recently to weigh in on the earnings. Solid Underlying...

Johnson & Johnson (NYSE: JNJ) came out with better-than-expected earnings on Tuesday, despite the strong headwind it faced from the rising dollar. The company reported first-quarter EPS of $1.56, compared to $1.54 in the same quarter last year, while revenue dropped to $17.4 billion, from $18...

Pfizer Inc. (NYSE: PFE) shares are showing good recent relative strength versus some of their pharmaceutical peers. The stock has had a great run of well over 300 percent since the 2009 lows. How much further can the stock go given the relatively low growth rates in both revenues and earnings?...

U.S. markets opened in negative territory to start the week following news reports that Japan's economy unexpectedly contracted in the third quarter. U.S. stocks rebounded after the European Central Bank's President Mario Draghi stating that the central bank remains "unanimous in...

Pfizer Inc. (NYSE: PFE) shares are sitting right below key technical resistance at $30.31. Is this a short-seller's dream set-up, or is it a stock that's gathering steam for a major breakout? What The Bulls See... • A healthy, Treasury-beating dividend yield of 3.50 percent...